VanEck Vectors Global Healthcare Leaders ETF HLTH
Fund description: HLTH gives investors exposure to a diversified portfolio of the largest international companies from the global healthcare sector. HLTH aims to provide investment returns before fees and other costs which track the performance of the Index.
Index description: The MarketGrader Developed Markets (ex-Australia) Health Care Index consists of 50 fundamentally sound companies with the best growth at a reasonable price (GARP) attributes in the healthcare sector from developed markets excluding Australia.
Management style: Replication
Country of domicile: Australia
as at 10-May-21
-
Exchange
ASX -
ASX code
HLTH -
Bloomberg index code
MGHCAUNR -
Index provider
MarketGrader -
NAV1
$10.25 -
Units outstanding1
4,400,000 -
Net assets1
$45.1M -
Number of holdings1
50 -
Inception date2
08-Sep-20 -
ASX commencement
10-Sep-20
2The date the ETF was seeded prior to quotation on ASX.
as at 10-May-21
-
Dividend frequency
1 each year -
Management costs p.a.
0.45% - Investment management team »
- Market Announcements
- HLTH Fact Sheet
- HLTH Fund Flyer
*The NAV is generally calculated daily after all markets are closed for that day based on the closing price of the securities on the relevant foreign stock exchange. The NAV is then converted to AUD based on the relevant London WM Reuters 4pm exchange rate. This means, due to Australia’s time zone, that the NAV will generally not be updated until around 12pm next business day.
Key points
Underlying Index
MarketGrader Developed Markets (ex-Australia) Health Care Index.
Overview
The Index consists of 50 fundamentally sound companies with the best growth at a reasonable price (GARP) attributes in the healthcare sector from developed markets excluding Australia.
Summary of Index methodology
The Index seeks to identify the largest companies in the health care sector with the best growth at a reasonable price (GARP) attributes, being the best drivers of long-term capital appreciation. The Index constituents are selected on the basis of the strength of their fundamentals across four factor categories: growth, value, profitability and cash flow. The 50 Index constituents are equally weighted at each semi-annual rebalance.
Rebalances
The Index is reviewed and rebalanced on a semi-annual basis, usually as of the close of the third Friday of March and September.
Index provider
MarketGrader.com Corporation ('MarketGrader'). MarketGrader is not a related body corporate of VanEck.
"MarketGrader" and "MarketGrader Developed Markets (Ex-Australia) Health Care Index" are trademarks of MarketGrader.com Corp. and have been licensed for use for certain purposes by VanEck. HLTH is based on the MarketGrader Developed Markets (ex-Australia) Health Care Index, but is not sponsored, endorsed, sold or promoted by MarketGrader, and MarketGrader makes no representation regarding the advisability of investing in HLTH.
Index profile
-
Bloomberg index code
MGHCAUNR -
Launch date
14-Aug-20 -
Base date
31-Dec-07 -
Rebalance Frequency
Semi-annually
Top ten index constituents (%) Download all daily index constituents as at 30-Apr-21
| Constituent name |
Ticker
|
Weightings (%) | |
|---|---|---|---|
| FISHER & PAYKEL HEALTHCARE C |
FPH NZ
|
2.37 | |
| UNITED THERAPEUTICS CORP |
UTHR US
|
2.36 | |
| METTLER-TOLEDO INTERNATIONAL |
MTD US
|
2.33 | |
| WEST PHARMACEUTICAL SERVICES |
WST US
|
2.29 | |
| STERIS PLC |
STE US
|
2.19 | |
| DANAHER CORP |
DHR US
|
2.18 | |
| SARTORIUS STEDIM BIOTECH |
DIM FP
|
2.16 | |
| GENMAB A/S |
GEN DC
|
2.15 | |
| CSPC PHARMACEUTICAL GROUP LT |
1093 HK
|
2.15 | |
| ALIGN TECHNOLOGY INC |
ALGN US
|
2.15 | |
| Top ten total (%) | 22.33 | ||
Index country weightings (%) as of 30-Apr-21
-
Country
Weightings (%) -
United States
70.6 -
France
5.9 -
Denmark
4.1 -
United Kingdom
4.0 -
South Korea
3.5 -
Japan
3.5 -
New Zealand
2.4 -
China
2.2 -
Italy
1.9 -
Switzerland
1.9 -
Total
100.0
Index sector weightings (%) as at 30-Apr-21
-
Sector
Weightings (%) -
Pharmaceuticals, Biotechnology
59.6 -
Health Care Equipment & Services
40.4 -
Total
100.0